Cadrenal Therapeutics, Inc. (CVKD) Form 8-K — Jun 29, 2026
Cadrenal Therapeutics appointed John P. Sharp as Interim Chief Financial Officer, effective June 25, 2026, replacing Quang X. Pham. Mr.
Key figures
- Sow retainer
- $25,000
- Max hours per week
- 24
- Director annual fee
- $35,000
- Interim cfo hourly rate
- $455
Price after filing
1 day: +16.8%7 days: +17.5%30 days: -29.7%
Close on the filing date to close N calendar days later (from $2.86). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.